Insights on Clinical Trials

  1. Understanding The Impact Of An RMP On Patient Risks Using Relational Risk Analysis 5/5/2025

    Using relational risk analysis, let's take a closer look at risk management plans for identifying and managing adverse reactions for administering a new therapy to a patient.

  2. Addressing Market Access Challenges As CGTs Expand To Larger Patient Populations 5/1/2025

    Navigating market access for advanced therapies requires new strategies. Explore ways to boost payer understanding, innovate pricing, and adapt treatment settings as these therapies expand.

  3. The Evolving Landscape Of Radiopharmaceuticals In Oncology Research 4/24/2025

    From selecting appropriate targeting molecules to optimizing dosing strategies and managing off-target effects, radiopharmaceutical development demands a tailored and strategic clinical approach.

  4. Navigating CGT Biotech's Financial Headwinds And The Path Forward 4/24/2025

    Dr. Ali Pashazadeh, Founder of Treehill Partners shares how CGT companies can navigate today’s biotech downturn by embracing integrated strategies, disciplined capital use, and bold leadership willing to rethink traditional models across innovation, manufacturing, and commercialization.

  5. Oncology Clinical Trials Case Study: I-SPY 2 & OpenClinica 4/17/2025

    The I-SPY 2 trial represents a pioneering effort in the field of oncology, specifically targeting the development of personalized treatments for breast cancer.

  6. Consent By Proxy: The Key To More Inclusive, More Reliable Trials 4/17/2025

    Explore innovative digital workflow designed specifically for Legally Authorized Representative (LAR) to help overcome the challenges of complex documentation and data management issues.

  7. EHR-To-EDC Success In A Complex, Adaptive Platform Trial 4/17/2025

    I-SPY 2, one of the longest-running adaptive platform trials in oncology, is revolutionizing breast cancer research through a dynamic, data-driven approach to evaluating novel therapies.

  8. Unlocking Recruitment Potential In Trial-Naïve Sites 4/17/2025

    Site Professional Support enabled this late-phase rheumatoid arthritis study to conduct complex patient visits despite its use of sites that lacked research experience and resources.

  9. Delivering Specialist Neurology Support 4/17/2025

    Explore a strategic approach to a Parkinson’s disease trial that leveraged a global infrastructure and multilingual workforce to provide seamless operational and clinical support.

  10. Enhance Access And Improve Retention In Rare Disease Trials With HTS 4/17/2025

    Home Trial Support (HTS) provides a solution to improving participant recruitment and retention during musculoskeletal studies.